Moreover, LMX1A was reported to function as a tumor suppressor in cervical, gastric, and ovarian cancers [25,28,29], and its methylation was significantly associated with recurrence in bladder cancer [26] and survival in stage I and II colorectal cancer patients [33]. This evidence concerns the gene LMX1A and ovarian carcinoma.